ViviGen MIS is the first cellular allograft optimized for minimally invasive surgeries, and it has been successfully used in minimally invasive spine procedures.
ViviGen includes a pre-filled cannula and sterile delivery device that allows bone allografts to be delivered with efficiency, reliability and precision.
Compared to a bone graft funnel, ViviGen offers better graft preparation and delivery performance, resulting in procedures that are three times faster, according to a March 8 press release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
